Skip to main content Help with accessibility Skip to main navigation

Recommendations

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and Criteria for Categorisation of Medicines

Documents

Grey
GALCANEZUMAB solution for injection (Emgality®▼) for prophylaxis of migraine
Date Posted: 25 - Jul - 2019
Body System: Nervous system
Green
GLIPTINS (Dipeptidylpeptidase-4 [DPP-4] inhibitors)
Date Posted: 24 - Apr - 2019
Body System: Endocrine System
Amber retained
GLP-1 mimetics in combination with insulin
Date Posted: 27 - Jul - 2016
Body System: Endocrine System
Black
GLUCOSAMINE and CHONDROITIN products
Date Posted: 13 - Feb - 2013
Body System: Musculoskeletal system
Red
GOLIMUMAB INJECTION (Simponi®) in non-radiographic axial spondyloarthritis
Date Posted: 31 - Jan - 2018
Body System: Musculoskeletal system
Red
GOLIMUMAB injection (Simponi®) in rheumatological conditions
Date Posted: 11 - Apr - 2018
Body System: Musculoskeletal system
Red
GUSELKUMAB solution for injection (Tremfya®▼) for Plaque Psoriasis
Date Posted: 09 - Nov - 2018
Body System: Skin